BTX insider filings

BlackRock Technology & Private Equity Term Trust — 39 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-09-17. Screen BTX transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Mahoney Francis C. — Director1———

Recent insider filings — BlackRock Technology & Private Equity Term Trust

FiledFormInsiderReported transactionsSource
2026-09-173Mahoney Francis C. — DirectorHoldings only — no transactions reportedEDGAR
2026-02-034Menge Steven ReidGrant/award (A): 4,136.94 (derivative) @ $7.85EDGAR
2026-02-034Kim TonyGrant/award (A): 29,270.83 (derivative) @ $7.85EDGAR
2025-12-224Fairbairn Robert W — DirectorSale (S): 21,936 @ $6.52 · Sale (S): 0.71 @ $6.55EDGAR
2025-07-104Saba Capital Management, L.P. — 10% owner
Weinstein Boaz — 10% owner
Other (J): 60,675,395 @ $7.49EDGAR
2022-09-214Sidhu Roger — Chief Medical OfficerOption exercise (M): 20,163 · Option exercise (M): 20,163 (derivative) @ $0EDGAR
2022-08-034Fiore Gregory — DirectorGrant/award (A): 95,100 (derivative) @ $0 · Grant/award (A): 165,800 (derivative) @ $0EDGAR
2022-08-034Angel Matthew — Interim President and CEO, DirectorGrant/award (A): 2,487,003 (derivative) @ $0EDGAR
2022-08-034Wexler William A. — DirectorGrant/award (A): 152,100 (derivative) @ $0 · Grant/award (A): 165,800 (derivative) @ $0EDGAR
2022-08-034Singer Nicholas Jason — DirectorGrant/award (A): 146,100 (derivative) @ $0 · Grant/award (A): 165,800 (derivative) @ $0EDGAR
2022-08-034Cherington Charles — DirectorGrant/award (A): 215,100 (derivative) @ $0 · Grant/award (A): 165,800 (derivative) @ $0EDGAR
2022-06-294DAmour Kevin — Chief Scientific OfficerOption exercise (M): 17,573 · Tax withholding (F): 6,077 @ $0.55 · Option exercise (M): 17,573 (derivative) @ $0EDGAR
2022-06-234Gurrola Sandra M — Vice President of FinanceOption exercise (M): 8,750 · Tax withholding (F): 3,586 @ $0.48 · Option exercise (M): 8,750 (derivative) @ $0EDGAR
2022-06-064Jackson Andrew C. — Chief Financial OfficerGrant/award (A): 664,800 (derivative) @ $0EDGAR
2022-03-174/ASidhu Roger — Chief Medical OfficerGrant/award (A): 142,100 (derivative) @ $0EDGAR
2022-03-174/ASial Jay — Chief Administration OfficerGrant/award (A): 117,200 (derivative) @ $0EDGAR
2022-03-174/ADAmour Kevin — Chief Scientific OfficerGrant/award (A): 138,400 (derivative) @ $0EDGAR
2022-03-174/AFederoff Howard J. — CEO & President, DirectorGrant/award (A): 413,700 (derivative) @ $0EDGAR
2022-03-174/AGurrola Sandra M — Vice President of FinanceGrant/award (A): 114,500 (derivative) @ $0EDGAR
2022-03-154Sidhu Roger — Chief Medical OfficerGrant/award (A): 142,100 (derivative) @ $0EDGAR
2022-03-154Sial Jay — Chief Administration OfficerGrant/award (A): 117,200 (derivative) @ $0EDGAR
2022-03-154DAmour Kevin — Chief Scientific OfficerGrant/award (A): 138,400 (derivative) @ $0EDGAR
2022-03-154Federoff Howard J. — CEO & President, DirectorGrant/award (A): 413,700 (derivative) @ $0EDGAR
2022-03-154Gurrola Sandra M — Vice President of FinanceGrant/award (A): 114,500 (derivative) @ $0EDGAR
2022-01-194Redman Heather B — DirectorGrant/award (A): 67,000 (derivative) @ $0EDGAR
2022-01-194ENRIGHT ERIN S. — DirectorGrant/award (A): 67,000 (derivative) @ $0EDGAR
2021-12-104Greenwood Luba — DirectorGrant/award (A): 67,000 (derivative) @ $0EDGAR
2021-12-104Cherington Charles — DirectorOther (J): 92 @ $0 · Grant/award (A): 67,000 (derivative) @ $0EDGAR
2021-12-104Mohr Erich — DirectorGrant/award (A): 67,000 (derivative) @ $0EDGAR
2021-12-104LANGER DENNIS — DirectorGrant/award (A): 67,000 (derivative) @ $0EDGAR
2021-09-224Sidhu Roger — See RemarksGrant/award (A): 161,300 (derivative) @ $0 · Grant/award (A): 80,650 (derivative) @ $0EDGAR
2021-08-204DENNY GEORGE P III — 10% ownerSale (S): 75,000 @ $16.06 · Purchase (P): 1 @ $14.35 · Purchase (P): 1 @ $14.11 · Purchase (P): 1 @ $11.99EDGAR
2021-07-194Sial Jay — See RemarksGrant/award (A): 71,000 (derivative) @ $0 · Grant/award (A): 35,700 (derivative) @ $0EDGAR
2021-06-304DAmour Kevin — See RemarksGrant/award (A): 140,580 (derivative) @ $0 · Grant/award (A): 70,290 (derivative) @ $0EDGAR
2021-06-224Gurrola Sandra M — Vice President of FinanceGrant/award (A): 35,000 (derivative) @ $0EDGAR
2021-06-214Cherington Charles — Director, 10% ownerSale (S): 200,000 @ $15.73 · Sale (S): 198,000 @ $15.74 · Sale (S): 2,000 @ $16.30EDGAR
2021-04-204Federoff Howard J. — See Remarks, DirectorGrant/award (A): 2,627,915 (derivative) @ $0 · Grant/award (A): 597,253 (derivative) @ $0EDGAR
2021-03-264Wolff Allen — Former Director and CEO, DirectorTax withholding (F): 9,944 @ $2.67EDGAR
2021-03-264Gurrola Sandra M — Former SVP of FinanceTax withholding (F): 6,094 @ $2.67EDGAR

Recent 8-K events — BlackRock Technology & Private Equity Term Trust

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-198-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-158-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-168-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-09-168-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-028-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-028-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-268-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-048-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-208-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-02-268-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=BTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs